anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

169,621-169,680 of 319,975

filter-aware
74
Contains footnotes 1-5 explaining segment reporting and asset impairment details.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
75
The table reconciles GAAP operating income to non-GAAP by adding back acquisition-related costs and adjustments.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
76
The table provides a detailed breakdown of non-GAAP adjustments including asset impairments, restructuring costs, and litigation expenses.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
77
The table provides a clear breakdown of adjustments including taxes, D&A, asset impairments, acquisition costs, and share-based compensation.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
78
Includes adjustments for foreign exchange rates, divestitures, and discontinuations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
79
The table breaks down revenue adjustments by segment, including foreign exchange impacts and divestitures/discontinuations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
80
The table is split into two main sections: calculation of organic revenue for current periods and calculation of organic revenue for prior periods, followed by a growth comparison.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
81
The table adjusts reported revenue for exchange rates and divestitures/discontinuations to arrive at organic revenue.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
82
Standard financial reconciliation table for non-GAAP metrics.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
83
The table provides a detailed breakdown of adjustments including impairments, restructuring, and other non-GAAP items.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
84
The right-hand sidebar acts as a navigation menu for the appendix section.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
85
This slide serves as a glossary/disclosure for non-GAAP metrics, with a navigation sidebar listing other metrics.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
86
The right-hand sidebar acts as a navigation menu for the appendix section.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
87
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
88
This slide serves as a glossary for financial metrics, likely part of a larger investor presentation.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
89
The right-hand sidebar acts as a navigation menu for the appendix section.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
90
This slide serves as a glossary/methodology reference for financial reporting.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
91
The slide features a sidebar navigation menu listing various non-GAAP metrics, with the current section 'Adjusted Cash Flows from Operations' and 'Bausch Pharma Total Revenue' highlighted.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Attention1 hit
02
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Attention1 hit
03
This is a standard pharmaceutical regulatory disclosure slide.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Attention1 hit
04
Includes specific clinical trial adverse reaction percentages and reporting instructions.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Attention1 hit
05
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Attention1 hit
06
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
07
The slide uses a hub-and-spoke style diagram to show how integrated capabilities feed into the pipeline.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
08
The slide uses a comparison structure to contrast two primary therapeutic areas.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
09
The slide uses a structured layout to categorize updates into three main pillars.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
10
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
11
Slide 11 from a BioNTech presentation.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
12
The slide lists five levers, though the title mentions six.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
13
Includes immunobridging data and efficacy summary across age groups.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
14
Slide 14 from a BioNTech presentation.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
15
Includes two distinct chart types: a dot plot with box-and-whisker elements for neutralization titers and a summary table for vaccine efficacy.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
16
Includes data from Israeli Ministry of Health and US healthcare records.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
17
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
18
The slide uses a hub-and-spoke diagram to connect a central patient/disease focus to multiple therapeutic modalities.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
19
The slide uses a three-column layout to categorize clinical progress. SITC refers to the Society for Immunotherapy of Cancer conference.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
20
Includes a process flow diagram illustrating the current standard of care and patient outcomes.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
21
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
22
Includes reference to Nature publication and SITC 2021 presentation.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
23
Includes trial schema (Part 1/2) and summary of patient characteristics, adverse events, and immune responses.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
24
The slide illustrates a dual-component therapy (CAR-T + RNA vaccine) and a multi-part clinical trial design.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
25
Slide 25 of a BioNTech presentation.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
26
Includes a diagram of the mechanism of action and a process flow for the clinical trial.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
27
The slide highlights immune activation markers and clinical disease control correlations, setting the stage for a Phase 2 trial.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
28
The slide outlines the mechanism of a bispecific antibody and the trial structure (dose escalation followed by expansion cohorts).BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
29
Clinical trial data summary slide.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
30
The slide uses a process flow diagram to describe the study design and three summary boxes for key clinical findings.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
31
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
32
The table shows a significant increase in commercial revenues and profit for 2021 compared to 2020.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
33
The chart breaks down revenue into four categories, with COVID-19 vaccine revenues being the primary driver.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
34
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
35
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
36
The slide uses a list-based structure to explain the acquisition of PhagoMed by BioNTech.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
37
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
38
The table uses a Gantt-style visualization for clinical trial phases, though all shown candidates are currently in Phase 1/2.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
39
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
40
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Blue Apron | Investor Presentation Deck | 10 slidesBlue Apron | Investor Presentation Deck | 10 slides · Blue Apron
Pitch deck Investor relations 1 hit
02
Blue Apron | Investor Presentation Deck | 10 slidesBlue Apron | Investor Presentation Deck | 10 slides · Blue Apron
Pitch deck Investor relations 1 hit